In the 24-week study of patients receiving JANUVIA as add-on therapy to insulin (with or without metformin), there were no adverse reactions reported regardless of investigator assessment of causality in 5% of patients and more commonly than in patients given placebo, except for hypoglycemia (see Table 3)
Concentration: 1000mcg/mL
Survodutide, the agent they are seeking to bring forward, exemplifies this approach
Appetite Control and Insulin Regulation It enhances insulin secretion, reduces glucagon release, and slows gastric emptying, leading to improved blood sugar levels and reduced food intake
Raghunandan M, Yeo JE, Walter R, Saito K, Harvey AJ, Ittershagen S, Lee E, Yang J, Hoatlin ME, Bielinsky AK, Hendrickson EA, Schrer O, Sobeck A (2020) Functional cross talk between the Fanconi anemia and ATRX/DAXX histone chaperone pathways promotes replication fork recovery
Leah Joseph offers Tirzepatide as a groundbreaking option for patients seeking safe and effective weight loss
